Category:solvents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Appearance: | colorless clear liquid (est) |
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Melting Point: | -25.00 °C. @ 760.00 mm Hg (est)
|
Boiling Point: | 202.00 °C. @ 760.00 mm Hg
|
Vapor Pressure: | 0.345000 mmHg @ 25.00 °C. (est) |
Vapor Density: | 3.4 ( Air = 1 ) |
Flash Point: | 187.00 °F. TCC ( 86.10 °C. ) (est)
|
logP (o/w): | -0.380 |
Soluble in: |
| water, 1.00E+06 mg/L @ 25 °C (exp) | | water, 2.483e+005 mg/L @ 25 °C (est) |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
BOC Sciences |
For experimental / research use only. |
N-Methyl-2-pyrrolidone
Odor: characteristic Use: N-Methyl-2-pyrrolidone is used as a versatile industrial solvent. |
Covalent Chemical |
N-methyl pyrrolidone
|
Eastman Chemical |
N-Methyl-2-Pyrrolidone (NMP)
Odor: characteristic Use: N-Methyl-2-Pyrrolidone (NMP) is a high boiling, polar aprotic, low viscosity liquid. NMP has a good solvency for a wide range of organic and inorganic compounds and it is miscible with water at all temperatures and has a high chemical and thermal stability. It is used as a solvent for engineering polymers and coating resins. The polar nature and the low surface tension of NMP makes it also an excellent cleaning medium and paint stripping solvent. |
ECSA Chemicals |
N-METHYLPYRROLIDONE
|
ECSA TRADE THE MOST UPDATED FINANCIAL PUBLICATION ON THE WORLD OF CHEMISTRY |
Glentham Life Sciences |
1-Methyl-2-pyrrolidinone
|
Indis NV |
For experimental / research use only. |
N-Methyl-2-Pyrrolidone
|
LyondellBasell Industries |
N-Methyl-2-pyrrolidone
|
Penta International |
1-METHYL-2-PYRROLIDINONE
|
Santa Cruz Biotechnology |
For experimental / research use only. |
1-Methyl-2-pyrrolidinone ≥99%
|
Shiva Chemicals and Pharmaceuticals |
n Methyl Pyrrolidone
|
Sigma-Aldrich |
For experimental / research use only. |
1-Methyl-2-pyrrolidinone anhydrous, 99.5%
|
Silver Fern Chemical |
n-Methylpyrrolidone
Odor: characteristic Use: N-Methylpyrrolidone is commonly used as a solvent for resins and acetylene, a pigment dispersant, in petroleum, microelectronics, plastics, textiles, agrochemicals, and pharmaceuticals. |
Taminco (Eastman) |
n-methylpyrrolidone
|
TCI AMERICA |
For experimental / research use only. |
1-Methyl-2-pyrrolidinone >99.0%(GC)
|
Universal Preserv-A-Chem Inc. |
MICROPURE EG
Odor: characteristic Use: NMP is used to recover certain hydrocarbons generated in the processing petrochemicals, such as the recovery of 1,3-butadiene and acetylene. It is used to absorb hydrogen sulfide from sour gas and hydrodesulfurization facilities. Due to its good solvency properties NMP is used to dissolve a wide range of polymers. It also used as a solvent for surface treatment of textiles, resins, and metal coated plastics or as a paint stripper. |
Safety Information:
Preferred SDS: View |
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
intravenous-dog LD50 63300 ug/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 922, 1987.
intraperitoneal-mouse LD50 3050 mg/kg United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. Vol. 8EHQ-1087-0695
intravenous-mouse LD50 54500 ug/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 922, 1987.
oral-mouse LD50 5130 mg/kg United States Environmental Protection Agency, Office of Pesticides and Toxic Substances. Vol. 8EHQ-1087-0695
intraperitoneal-rat LD50 2472 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 1581, 1976.
intravenous-rat LD50 80500 ug/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 922, 1987.
oral-rat LD50 3914 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 1581, 1976.
unreported-rat LD50 7000 mg/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 408, 1969.
|
Dermal Toxicity: |
skin-rabbit LD50 8000 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. Vol. 1, Pg. 84, 1974.
subcutaneous-rat LD50 > 2000 mg/kg United States Patent Document. Vol. #4882359
|
Inhalation Toxicity: |
inhalation-rat LCLo 1000 mg/m3 National Technical Information Service. Vol. OTS0534725
|
Safety in Use Information:
Category: | solvents |
Recommendation for 1-methyl-2-pyrrolidinone usage levels up to: | | not for fragrance use.
|
|
Recommendation for 1-methyl-2-pyrrolidinone flavor usage levels up to: |
| not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| M-pyrol | N- | methyl pyrrolidone | N- | methyl-2-ketopyrrolidine | N- | methyl-2-pyrolidinone | N- | methyl-2-pyrrolidinone | 1- | methyl-2-pyrrolidone | N- | methyl-2-pyrrolidone | N- | methyl-a-pyrrolidinone | N- | methyl-a-pyrrolidone | 1- | methyl-pyrrolidin-2-one | N- | methyl-pyrrolidone | N- | methylbutyrolactam | 1- | methylpyrrolidin-2-one | N- | methylpyrrolidin-2-one | | methylpyrrolidinone | N- | methylpyrrolidinone | N- | methylpyrrolidione | N- | methylpyrrolidone | | methylpyrrolidone, N- | | pyrrolidin-2-one, 1-methyl- | 2- | pyrrolidinone, 1-methyl- | | pyrrolidinone, methyl- | 2- | pyrrolidinone, methyl- | 2- | pyrrolidone, 1-methyl |
Articles:
PubMed:Homogeneous ring opening graft polymerization of ɛ-caprolactone onto xylan in dual polar aprotic solvents. |
PubMed:Star-shaped poly(L-lactide)-b-poly(lactobionamidoethyl methacrylate) with porphyrin core: synthesis, self-assembly, singlet oxygen research and recognition properties. |
PubMed:Direct synthesis of α-trifluoromethyl ketone from (hetero)arylacetylene: design, intermediate trapping, and mechanistic investigations. |
PubMed:Effective liquid-phase exfoliation and sodium ion battery application of MoS2 nanosheets. |
PubMed:Liquid-phase exfoliation of graphene in organic solvents with addition of naphthalene. |
PubMed:Ultrahigh PEMFC performance of a thin-film, dual-electrode assembly with tailored electrode morphology. |
PubMed:Carbon nanotube poroshell silica as a novel stationary phase for fast HPLC analysis of monoclonal antibodies. |
PubMed:Development and pharmacokinetic evaluation of a curcumin co-solvent formulation. |
PubMed:Fouling mitigation in humic acid ultrafiltration using polysulfone/SAPO-34 mixed matrix membrane. |
PubMed:Chemical and biological characterization of wastewater generated from hydrothermal liquefaction of Spirulina. |
PubMed:Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging. |
PubMed:Non-covalent functionalisation of monolithic silica for the development of carbon nanotube HPLC stationary phases. |
PubMed:Porosity and mechanically optimized PLGA based in situ hardening systems. |
PubMed:Effects of pentacene-doped PEDOT:PSS as a hole-conducting layer on the performance characteristics of polymer photovoltaic cells. |
PubMed:Partial dissolution of ACQ-treated wood in lithium chloride/N-methyl-2-pyrrolidinone: separation of copper from potential lignocellulosic feedstocks. |
PubMed:Delivery of atovaquone and proguanil across sublingual membranes, in vitro. |
PubMed:Rare earth fluoride nanoparticles obtained using charge transfer complexes: a versatile and efficient route toward colloidal suspensions and monolithic transparent xerogels. |
PubMed:Effects of electrochemical reduction reactions on the biodegradation of recalcitrant organic compounds (ROCs) and bacterial community diversity. |
PubMed:Facile synthesis of MOF-177 by a sonochemical method using 1-methyl-2-pyrrolidinone as a solvent. |
PubMed:Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems. |
PubMed:Noninvasive characterization of in situ forming implants using diagnostic ultrasound. |
PubMed:SAXS and NMR analysis for the cast solvent effect on sPEEK membrane properties. |
PubMed:Pyrolysis of waste polypropylene and characterisation of tar. |
PubMed:The use of oxygen uptake rate to monitor discovery of microbial and enzymatic biocatalysts. |
PubMed:Human bone derived cell culture on PLGA flat sheet membranes of different lactide:glycolide ratio. |
PubMed:Kinetics of amide formation through carbodiimide/N-hydroxybenzotriazole (HOBt) couplings. |
PubMed:[Discharge ion mobility spectrometry of ketonic organic compounds]. |
PubMed:Control of EOF in CE by different ways of application of radial electric field. |
PubMed:Phase separation micromolding: a new generic approach for microstructuring various materials. |
PubMed:Poly(lactic-co-glycolic acid) hollow fibre membranes for use as a tissue engineering scaffold. |
PubMed:Unexpected reaction of beta-cyclodextrin tosylate with pyrrolidinones. |
PubMed:Examination of soil contaminated by coal-liquids by size exclusion chromatography in 1-methyl-2-pyrrolidinone solution to evaluate interference from humic and fulvic acids and extracts from peat. |
PubMed:[Effect of tegaserod on the serotonin content in rat ileocaecal mucosa under partial restraint stress]. |
PubMed:Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance. |
PubMed:Relevance of Frank's solvent classification as typically aqueous and typically non-aqueous to activities of firefly luciferase, alcohol dehydrogenase, and alpha-chymotrypsin in aqueous binaries. |
PubMed:Wetting kinetics of modified polyimide surfaces: interactions with polar solvents. |
PubMed:Estimation of the molecular mass range of the tar from pyrolysis of casein by gas chromatography-mass spectrometry, probe mass spectrometry and size exclusion chromatography with 1-methyl-2-pyrrolidinone as eluent. |
PubMed:Use of an 8(1)3(2) asymmetrical factorial design for the in vitro evaluation of ondansetron permeation through human epidermis. |
PubMed:Thin-layer chromatography of pitch and a petroleum vacuum residue. Relation between mobility and molecular size shown by size-exclusion chromatography. |
PubMed:Size-exclusion chromatography of large molecules from coal liquids, petroleum residues, soots, biomass tars and humic substances. |
PubMed:Through-shell alkyllithium additions and borane reductions. |
PubMed:The effect of Pluronic on the protein release kinetics of an injectable drug delivery system. |
PubMed:Toxicokinetics and metabolism of N-[14C]methylpyrrolidone in male Sprague-Dawley rats. A saturable NMP elimination process. |
PubMed:Dermal exposure to aqueous solutions of N-methyl pyrrolidone. |
PubMed:Pyrolysis-gas chromatography/mass spectrometry of fractions separated from a low-temperature coal tar: an attempt to develop a general method for characterising structures and compositions of heavy hydrocarbon liquids. |
PubMed:A new, efficient glycosylation method for oligosaccharide synthesis under neutral conditions: preparation and use of new DISAL donors. |
PubMed:Study of the polymerization of anthracene oil with AlCl3 by chromatography and related techniques. |
PubMed:Liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry determination of N-methylpyrrolidinone in riverine biofilms. |
PubMed:Structural characterisation of Baltic amber and its solvent extracts by several mass spectrometric methods. |
PubMed:Syntheses and characterization of anti-inflammatory dinuclear and mononuclear zinc indomethacin complexes. Crystal structures of [Zn2(indomethacin)4(L)2] (L = N,N-dimethylacetamide, pyridine, 1-methyl-2-pyrrolidinone) and [Zn(indomethacin)2(L1)2] (L1 = ethanol, methanol). |
PubMed:HPTLC screening assay for urinary cotinine as biomarker of environmental tobacco smoke exposure among male adolescents. |
PubMed:Identification of organically associated trace elements in wood and coal by inductively coupled plasma mass spectrometry. |
PubMed:Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. |
PubMed:Photodynamic activities and biodistribution of fluorinated zinc phthalocyanine derivatives in the murine EMT-6 tumour model. |
PubMed:Synthesis, Structure, and Thiolysis Reactions of Pyridine Soluble Alkaline Earth and Yttrium Thiolates. |
PubMed:Determination of 5-hydroxy-N-methylpyrrolidone and 2-hydroxy-N-methylsuccinimide in human urine. |
PubMed:1-Methyl-2-pyrrolidinone (NMP) does not induce structural and numerical chromosomal aberrations in vivo. |
PubMed:Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one. |
PubMed:Synthesis of insulin-like growth factor I using N-methyl pyrrolidinone as the coupling solvent and trifluoromethane sulphonic acid cleavage from the resin. |
PubMed:Transdermal absorption of radioprotectors using permeation-enhancing vehicles. |
PubMed:Induction of chromosome loss by mixtures of organic solvents including neurotoxins. |
PubMed:Aprotic polar solvents that affect porcine brain tubulin aggregation in vitro induce aneuploidy in yeast cells growing at low temperatures. |
PubMed:Investigations of aneuploidy-inducing chemical combinations in Saccharomyces cerevisiae. |
PubMed:Aneuploidy induction in Saccharomyces cerevisiae by two solvent compounds, 1-methyl-2-pyrrolidinone and 2-pyrrolidinone. |
PubMed:Nonheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12. |
PubMed:Degradation of chlorthalidone in methanol: kinetics and stabilization. |
|